Esther M. van Wezel

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Gudrun Schleiermacher, Jan Koster, Javed Khan, 2015, Nature Genetics.

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel

R. Versteeg, H. Caron, J. Koster, 2019, JCO precision oncology.